Publications - Helin Norberg lab

Publications from Helin Norberg's lab.

Selected publications

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Klionsky et al.
Autophagy 2021 Feb 8;1-382. doi: 10.1080/15548627.2020.1797280. Online ahead of print

Mutant p53 as a Regulator and Target of Autophagy.
Shi Y, Norberg E, Vakifahmetoglu-Norberg H
Front Oncol 2021 Feb 3;10:607149

Quantitative proteomic analysis of temporal lysosomal proteome and the impact of the KFERQ-like motif and LAMP2A in lysosomal targeting.
Kacal M, Zhang B, Hao Y, Norberg E, Vakifahmetoglu-Norberg H
Autophagy 2021 Jan;():1-10

The deubiquitinase JOSD2 is a positive regulator of glucose metabolism.
Krassikova L, Zhang B, Nagarajan D, Queiroz AL, Kacal M, Samakidis E, Vakifahmetoglu-Norberg H, Norberg E
Cell Death Differ 2020 Oct;():

Systematic analysis reveals a functional role for STAMBPL1 in the epithelial-mesenchymal transition process across multiple carcinomas.
Ambroise G, Yu TT, Zhang B, Kacal M, Hao Y, Queiroz AL, Ouchida AT, Lindskog C, Norberg E, Vakifahmetoglu-Norberg H
Br J Cancer 2020 Sep;123(7):1164-1177

Illustration describing CMA thru a arrow board
Figure legend: Illustration on the new role for CMA in the control of proteins involved in the eukaryotic translation initiation in cancer cells. Medical illustrator: Mattias Karlén.

Targetome analysis of chaperone-mediated autophagy in cancer cells.
Hao Y, Kacal M, Ouchida AT, Zhang B, Norberg E, Vakifahmetoglu-Norberg H
Autophagy 2019 09;15(9):1558-1571

USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2.
Ouchida AT, Kacal M, Zheng A, Ambroise G, Zhang B, Norberg E, Vakifahmetoglu-Norberg H
Biochem Biophys Res Commun 2018 08;502(4):429-434

Resistant to Targeted Therapy - Aim for Metabolic Liabilities.
Queiroz AL, Vakifahmetoglu-Norberg H, Norberg E
Theranostics 2018 ;8(7):2061-2063

Cover of Molecular and Cellular Biology. Volume 37, issue 24.
Cover of Molecular and Cellular Biology. Volume 37, issue 24.

Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism.
Eriksson M, Ambroise G, Ouchida AT, Lima Queiroz A, Smith D, Gimenez-Cassina A, Iwanicki MP, Muller PA, Norberg E, Vakifahmetoglu-Norberg H
Mol Cell Biol 2017 Dec;37(24):

Characterization of the Role of the Malate Dehydrogenases to Lung Tumor Cell Survival.
Zhang B, Tornmalm J, Widengren J, Vakifahmetoglu-Norberg H, Norberg E
J Cancer 2017 ;8(11):2088-2096

PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis.
Zhang B, Zheng A, Hydbring P, Ambroise G, Ouchida AT, Goiny M, Vakifahmetoglu-Norberg H, Norberg E
Cell Rep 2017 06;19(11):2289-2303

# Co-corresponding author. (Selected as ‘Issue Highlight’ by Cell Reports)

Activation of chaperone-mediated autophagy as a potential anticancer therapy.
Galan-Acosta L, Xia H, Yuan J, Vakifahmetoglu-Norberg H
Autophagy 2015 ;11(12):2370-1

Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death.
Xia HG, Najafov A, Geng J, Galan-Acosta L, Han X, Guo Y, Shan B, Zhang Y, Norberg E, Zhang T, Pan L, Liu J, Coloff JL, Ofengeim D, Zhu H, Wu K, Cai Y, Yates JR, Zhu Z, Yuan J, Vakifahmetoglu-Norberg H
J Cell Biol 2015 Aug;210(5):705-16

Highlighted in a special collection of JCB articles in the topic of autophagy.

Activation of necroptosis in multiple sclerosis.
Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, Ye J, Zhang X, Chang A, Vakifahmetoglu-Norberg H, Geng J, Py B, Zhou W, Amin P, Berlink Lima J, Qi C, Yu Q, Trapp B, Yuan J
Cell Rep 2015 Mar;10(11):1836-49

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Klionsky et al.
Autophagy. 2016;12(1):1-222

Highly cited paper received enough citations to place it in the top 1% of the academic field of Molecular Biology & Genetics based on a highly cited threshold for the field and publication year
(Web of Science).

Pharmacologic agents targeting autophagy.
Vakifahmetoglu-Norberg H, Xia HG, Yuan J
J Clin Invest 2015 Jan;125(1):5-13

Highly cited paper received enough citations to place it in the top 1% of the academic field of Clinical Medicine based on a highly cited threshold for the field and publication year. (Web of Science).

Chaperone-mediated autophagy degrades mutant p53.
Vakifahmetoglu-Norberg H, Kim M, Xia HG, Iwanicki MP, Ofengeim D, Coloff JL, Pan L, Ince TA, Kroemer G, Brugge JS, Yuan J
Genes Dev 2013 Aug;27(15):1718-30

Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.
Py BF, Kim MS, Vakifahmetoglu-Norberg H, Yuan J
Mol Cell 2013 Jan;49(2):331-8

Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13.
Liu J, Xia H, Kim M, Xu L, Li Y, Zhang L, Cai Y, Norberg HV, Zhang T, Furuya T, Jin M, Zhu Z, Wang H, Yu J, Li Y, Hao Y, Choi A, Ke H, Ma D, Yuan J
Cell 2011 Sep;147(1):223-34

All publications

Link to a complete list of Helin Norberg's publications.